Lunai Bioworks Inc. — Director's Dealing 2016

Sep 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2016-09-20

Reporting Person: PETERSEN ALDO (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-20	Stock Option (Right to Buy)	$2.00	A	300000	Acquired	2019-12-31	Common Stock (300000)	Indirect

Footnotes

F1: The stock options were issued to APE Invest A/S, a Danish company controlled by Mr. Petersen.